Key result
Alzheimer's disease linked to ~42% higher 3-year mortality after emergency coronary revascularization.
Why the study?
Little was known about the incidence and postoperative outcomes of coronary revascularizations according to electivity in persons with Alzheimer's disease.
Does Alzheimer's disease increase mortality and readmission in patients undergoing coronary revascularization?
Cohort (n=246,347)
Does Alzheimer's disease increase mortality and readmission in patients undergoing coronary revascularization?
Hazard Ratio: 1.42 (95% CI 1.15–1.74)
Patients with Alzheimer's disease have similar readmission and mortality outcomes following elective coronary revascularization compared to those without, suggesting elective procedures should not be withheld solely based on an AD diagnosis.
Supports caution with emergency revascularization in AD; leaves open elective risk and whether procedures should be withheld.
BACKGROUND: Little is known on the incidence and postoperative outcomes of revascularizations according to electivity in persons with Alzheimer's disease (AD). METHODS: The Medication Use and Alzheimer's disease (MEDALZ) cohort includes 70 718 community dwellers diagnosed with incident AD during 2005-2011 in Finland. For each person with AD, 1-4 age-, sex-, and hospital district-matched comparison persons without AD were identified. Altogether 448 persons with AD and 5909 without AD underwent revascularization during the follow-up. The outcomes were 30-day and 90-day re-admission rate after discharge, and all-cause 1-year and 3-year mortality. Risk of outcomes in persons with AD were compared to those without AD using Cox proportional hazard models adjusted with age, sex, comorbidities, statin use, revascularization type, length of stay, and support at discharge. RESULT: People with AD had less revascularizations (adjusted hazard ratio 0.24, 95% confidence interval 0.22-0.27). Emergency procedures were more common (42.6% vs 33.1%) than elective procedures (34.2% vs 48.6%) among people with AD. There was no difference in 30-day readmissions (0.97, 0.80-1.17) or 1-year mortality (1.04, 0.75-1.42) and 90 days readmission risk was lower in persons with AD (0.85, 0.74-0.98). People with AD had higher 3-year mortality (1.42, 1.15-1.74), but the risk increase was observed only for emergency (1.71, 1.27-2.31), not for elective procedures (0.96, 0.63-1.46). CONCLUSION: People with AD did not have worse readmission and mortality outcomes following elective revascularization. These findings in conjunction with lower revascularization rate especially for elective procedures raise questions on the threshold for elective procedures in people with AD.
No takes yet. Share an insight, caveat, or question.
Vu et al. (2021) conducted a cohort in Alzheimer's disease (n=246,347). Alzheimer's disease vs. People without Alzheimer's disease was evaluated on All-cause 3-year mortality (aHR 1.42, 95% CI 1.15-1.74). People with Alzheimer's disease had a higher 3-year mortality risk following coronary revascularization compared to those without the disease (HR 1.42), though this risk increase was observed only for emergency procedures.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: